Safety and Efficacy of Opicinumab in Acute Optic Neuritis (RENEW): A Randomised, Placebo-Controlled, Phase 2 Trial

The Lancet Neurology- United Kingdom

doi 10.1016/s1474-4422(16)30377-5


Related search